NUTROPIN AQ PEN (SOMATROPIN) SOLUTION FOR INJECTION 10 MG

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04 report with the FDA on 2009-11-09 for NUTROPIN AQ PEN (SOMATROPIN) SOLUTION FOR INJECTION 10 MG manufactured by Genentech, Inc..

Event Text Entries

[1252619] Consistently getting more doses per cartridge than they should when using nutropin aq 20 pen [medication error]. Case description: this case, mfr control number (b)(4), is a spontaneous report from the united states referring to a male pt of unk age. The pt's mother reported this case. No past medical history, concomitant medications, allergies, or concurrent conditions were reported. On an unspecified date reported as six months ago, the pt started treatment with nutropin aq (1. 6 mg, frequency and route not reported) and nutropin aq pen (dose, frequency and route not reported) for an unk indication. The nutropin aq lot number was not reported. The nutropin aq pen lot number was reported as b105. The first puncture date of the b105 was not reported. This was the pt's first pen. It was not reported whether the pt continued or discontinued use with lot number b105. It was not reported whether the pt switched to another lot number. On an unspecified date, the pt presented with consistently getting more doses per cartridge than they should when using nutropin aq 20 pen (medication error). It was reported that the pt received 13-15 doses per 20 mg cartridge instead of 12. 5 doses. Relevant lab tests, treatment for the event and action take with nutropin aq and nutropin aq pen were not reported. The mother was to send the nutropin aq pen to genentech, inc. The event outcome was not reported. The consumer did not provide an assessment of the event medication error in relation to nutropin aq and nutropin aq pen. No other possible etiological factors were identified. This report was forwarded to genentech, inc. Product quality and assigned (b)(4). Additional info is being requested. If received, the case will be updated accordingly.
Patient Sequence No: 1, Text Type: D, B5


[8307913] .
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2917293-2009-00006
MDR Report Key1553696
Report Source04
Date Received2009-11-09
Date of Report2009-10-28
Date Mfgr Received2009-10-28
Date Added to Maude2011-03-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactJAMES NICKAS, PHARM.D.
Manufacturer Street1 DNA WAY
Manufacturer CitySOUTH SAN FRANCISCO CA 94080
Manufacturer CountryUS
Manufacturer Postal94080
Manufacturer Phone6502255591
Manufacturer G1GENENTECH, INC.
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNUTROPIN AQ PEN (SOMATROPIN) SOLUTION FOR INJECTION 10 MG
Generic NameNONE
Product CodeKZE
Date Received2009-11-09
Lot NumberB105
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerGENENTECH, INC.


Patients

Patient NumberTreatmentOutcomeDate
10 2009-11-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.